0001567619-22-002523.txt : 20220204
0001567619-22-002523.hdr.sgml : 20220204
20220204165136
ACCESSION NUMBER: 0001567619-22-002523
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220202
FILED AS OF DATE: 20220204
DATE AS OF CHANGE: 20220204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HANNAH ALISON L.
CENTRAL INDEX KEY: 0001645600
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37587
FILM NUMBER: 22594175
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytomX Therapeutics, Inc.
CENTRAL INDEX KEY: 0001501989
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273521219
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650.515.3185
MAIL ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc1.xml
FORM 4
X0306
4
2022-02-02
0
0001501989
CytomX Therapeutics, Inc.
CTMX
0001645600
HANNAH ALISON L.
C/O CYTOMX THERAPEUTICS, INC.
151 OYSTER POINT BLVD., STE. 400
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Medical Officer
Common Stock
2022-02-02
4
A
0
22500
0.00
A
22500
D
Stock Option (Right to Buy)
4.13
2022-02-02
4
A
0
135000
0.00
A
2032-02-01
Common Stock
135000
135000
D
Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on March 15 of each year, with the first 1/4th vesting on March 15, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Includes 22,500 RSUs.
1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.
/s/ Lloyd Rowland, as Attorney-in-Fact for Alison L. Hannah
2022-02-04